Healthcare - Medical - Diagnostics & Research - NASDAQ - HK
$ 4.5
-5.26 %
$ 55 M
Market Cap
-1.32
P/E
CASH FLOW STATEMENT
-13.8 M
OPERATING CASH FLOW
-83 M
INVESTING CASH FLOW
-4.7 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Prenetics Global Limited
| Net Income | -62.7 M |
| Depreciation & Amortization | 7.79 M |
| Capital Expenditures | -912 K |
| Stock-Based Compensation | 10.6 M |
| Change in Working Capital | 24.2 M |
| Others | 675 K |
| Free Cash Flow | -14.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (62.7) | (190.5) | (174.0) | (2.0) | (20.2) |
| Depreciation & Amortization | 7.8 | 7.5 | 7.3 | 2.4 | 2.2 |
| Deferred Income Tax | (0.4) | 7.1 | 3.7 | (1.9) | (0.7) |
| Stock Based Compensation | 10.6 | 31.6 | 22.5 | 1.6 | 3.9 |
| Other Operating Activities | 6.8 | 192.5 | 160.5 | 4.8 | 2.6 |
| Change in Working Capital | 24.2 | (33.8) | (6.6) | (7.8) | 10.2 |
| Cash From Operations | (13.8) | 14.5 | 13.4 | (2.9) | (1.9) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.9) | (6.3) | (11.4) | (3.1) | (0.4) |
| Other Items | (82.0) | (39.8) | (10.6) | (2.9) | (4.2) |
| Cash From Investing Activities | (83.0) | (46.1) | (22.0) | (6.0) | (4.6) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | (1.2) | (0.7) | 0 | 0 | 0 |
| Total Debt Repaid | (3.2) | (1.9) | (1.3) | (0.6) | (0.5) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.2) | 145.7 | 30.6 | 12.5 | 65.6 K |
| Cash From Financing Activities | (4.7) | 143.3 | 29.3 | 11.8 | (0.6) |
| CHANGE IN CASH | |||||
| Net Change In Cash | (101.0) | 111.4 | 20.8 | 3.0 | (7.3) |
| FREE CASH FLOW | |||||
| Free Cash Flow | (14.7) | 8.2 | 2.0 | (5.9) | (2.3) |